NASDAQ · Financial Statements
Checkpoint Therapeutics, Inc. (CKPT) Financial Statements
$4.26
NASDAQ: CKPT
Market Cap $367.72M
Overview Financials Dividend Checkpoint Therapeutics, Inc. most recently reported annual revenue of $0, net profit of $-56.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2020 2021 2022 2023 2024 Revenue $1.0M $0 $0 $0 $0 Operating Profit $-23.0M $-57.0M $-58.0M $-52.0M $-56.0M Net Profit $-23.0M $-57.0M $-63.0M $-52.0M $-56.0M EPS $-4.13 $-7.45 $-7.09 $-2.77 $-1.42 Op Margin -2170.3% -21165.3% -30381.8% -50629.1% -137009.8%
Balance Sheet (USD)
Metric 2020 2021 2022 2023 2024 Total Assets $43.0M $56.0M $13.0M $5.0M $7.0M Total Liabilities $7.0M $26.0M $33.0M $18.0M $20.0M Cash $41.0M $55.0M $12.0M $5.0M $7.0M Borrowings $0 $0 $0 $0 $0
Cash Flow (USD)
Metric 2020 2021 2022 2023 2024 Operating Cash Flow $-17.0M $-26.0M $-58.0M $-48.0M $-31.0M Investing Cash Flow $0 $0 $0 $0 $0 Financing Cash Flow $-2.0M $-1.0M $-3.0M $7.0M $7.0M Net Cash Flow $15.0M $14.0M $-43.0M $-7.0M $2.0M Free Cash Flow $-17.0M $-26.0M $-58.0M $-48.0M $-31.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.00 EV / EBITDA -6.43 FCF Yield -8.46% Quick Ratio 0.37 Interest Coverage 0.00 Return 1Y — Return 3Y — Return 5Y —
Screens featuring this stock